Vancouver-based psychedelic company Ketamine One has begun trading its common shares on the US over-the-counter (OTCQB) Venture Market under the ticker symbol “KONEF,” effective from January 12, 2022. The listing is an upgrade from the company’s listing on the OTC Pink Market.
The company will continue trading on the Neo Exchange under the ticker symbol “MEDI” and Frankfurt Stock Exchange (FSE) under the ticker symbol “FY0.”
Ketamine One believes the OTCQB uplisting will broaden its visibility among potential US investors and improve the liquidity of the company’s existing and prospective shareholders to enhance shareholder value. It also previously received approval from the Depository Trust Company (DTC) in the US to enable the electronic settlement of its shares.